Oramorph sr and Combivent drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Oramorph sr (morphine sulfate) and Combivent (albuterol sulfate; ipratropium bromide). Common drug interactions include pallor among females and respiratory failure among males.

The phase IV clinical study analyzes what interactions people have when they take Oramorph sr and Combivent. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Oramorph sr?

Oramorph sr has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 2,897 Oramorph sr users. Check the latest studies of Oramorph sr.

What is Combivent?

Combivent has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in asthma. eHealthMe is studying from 35,341 Combivent users. Check the latest studies of Combivent.

On Jul, 13, 2026

19 people who take Oramorph sr and Combivent together, and have interactions are studied.

Oramorph sr and Combivent drug interactions.

What are the common drug interactions of Oramorph Sr and Combivent, by gender? *:

female:

Pallor
Peripheral vascular disorder
Pleural effusion (water on the lungs)
Productive cough
Pulmonary embolism (blockage of the main artery of the lung)
Pulmonary hypertension (increase in blood pressure in the lung artery)
Pulmonary oedema (fluid accumulation in the lungs)
Pulse pressure decreased
Rales (an abnormal respiratory sound characterized by fine crackles)
Renal disorder (kidney disease)

male:

Respiratory failure (inadequate gas exchange by the respiratory system)
General physical health deterioration (weak health status)
Productive cough
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Haematemesis (vomiting of blood)
Pleuritic pain
Vomiting
Anaesthetic complication neurological
Asthenia (weakness)
Bacterial infection

What are the common drug interactions of Oramorph Sr and Combivent, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Oedema peripheral (superficial swelling)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Pulmonary embolism (blockage of the main artery of the lung)
Sputum discoloured
Respiratory failure (inadequate gas exchange by the respiratory system)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Chest pain
General physical health deterioration (weak health status)
Hypoxia (low oxygen in tissues)
Pneumonia

60+:

Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Vomiting
Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
Ascites (accumulation of fluid in the abdominal cavity)
Asthenia (weakness)
Atelectasis (partial or complete collapse of the lung)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Bacterial infection
Bradyarrhythmia (heart slowness)

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 15.79%
Polymyositis (inflammatory muscle disease that causes weakness of the skeletal muscles): 2 people, 10.53%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 5.26%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 1 person, 5.26%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 5.26%
Behcet's Syndrome (involves inflammation of the blood vessels): 1 person, 5.26%
Back Pain: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Oramorph sr and Combivent?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously